• Bone Therapeutics secures EUR 5 million financing

    Tuesday April 12th 2022

  • V-Bio Ventures raises EUR 110 million for its second fund and expands team

    Thursday March 31st 2022

  • V-Bio Ventures’ Portfolio Company Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticals

    Wednesday March 16th 2022

  • 2.3 million grant awarded to Flen Health by the Ministry of the Economy of Luxembourg (MECO)

    Monday February 28th 2022

  • Newton Biocapital launches a new fund with initial capital commitments of EUR 50 million and target size of EUR 150 million

    Tuesday February 15th 2022

  • Mithra obtains equity funding for up to EUR 100 million

    Monday February 7th 2022

  • V-Bio Ventures raises additional capital to support young biotech companies

    Thursday January 27th 2022

  • ElmediX raises nearly 12 million euros to develop innovative heat technology to fight cancer

    Tuesday January 25th 2022

  • Your news here?

  • BioStrand secures second VLAIO research grant

    Thursday January 13th 2022

  • New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster

    Monday December 6th 2021

  • Celyad Oncology announces $32.5 million private placement with Fortress Investment Group

    Monday December 6th 2021


Strategic Partners